Gland Pharma informs about press release

29 Apr 2024 Evaluate

Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; Gland Pharma has informed that it attached announcement regarding the receipt of US FDA approval for Cetrorelix Acetate for Injection, 0.25 mg/vial, Single-Dose Vial.

The above information is a part of company’s filings submitted to BSE.

Gland Pharma Share Price

1785.75 12.65 (0.71%)
16-May-2024 15:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1535.40
Dr. Reddys Lab 5850.00
Cipla 1424.45
Zydus Lifesciences 1009.25
Lupin 1661.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.